Juvenile-Onset Recurrent Respiratory Papillomatosis Diagnosis and Management – A Developing Country Review

References

• Seedat RY, Combrinck CE, Burt FJ. HPV associated with recurrent respiratory papillomatosis. Future Virol. 2013;8(5):477–492. doi:10.2217/fvl.13.31
   Web of Science ®Google Scholar
• Seedat RY, Schall R. Age of diagnosis, incidence and prevalence of recurrent respiratory papillomatosis-A South African perspective. Clin Otolaryngol. 2018;43(2):533–537. doi:10.1111/coa.1301629054106
   PubMed Web of Science ®Google Scholar
• Ilboudo M, Zohoncon TM, Traore IMA, et al. Implication of low risk human papillomaviruses, HPV6 and HPV11 in laryngeal papillomatosis in Burkina Faso. Am J Otolaryngol - Head Neck Med Surg. 2019;40(3):368–371. doi:10.1016/j.amjoto.2019.02.003
   Web of Science ®Google Scholar
• Matinhira N, Soko ND, Bandason T, et al. Human papillomavirus types causing recurrent respiratory papillomatosis in Zimbabwe. Int J Pediatr Otorhinolaryngol. 2019;116:147–152. doi:10.1016/j.ijporl.2018.10.03630554686
   PubMed Web of Science ®Google Scholar
• Sanchez GI, Jaramillo R, Cuello G, et al. Human papillomavirus genotype detection in recurrent respiratory papillomatosis (RRP) in Colombia. Head Neck. 2013;35(2):229–234. doi:10.1002/hed.2295322367608
   PubMed Web of Science ®Google Scholar
• San Giorgi MRM, van den Heuvel ER, Tjon Pian Gi REA, et al. Age of onset of recurrent respiratory papillomatosis: a distribution analysis. Clin Otolaryngol. 2016;41(5):448–453. doi:10.1111/coa.1256526460806
   PubMed Web of Science ®Google Scholar
• Silverberg MJ, Thorsen P, Lindeberg H, Ahdieh-Grant L, Shah KV. Clinical course of recurrent respiratory papillomatosis in Danish children. Arch Otolaryngol Head Neck Surg. 2004;130(6):711–716. doi:10.1001/archotol.130.6.71115210551
   PubMedGoogle Scholar
• Novakovic D, Cheng ATL, Cope DH, Brotherton JML. Estimating the prevalence of and treatment patterns for juvenile onset recurrent respiratory papillomatosis in Australia pre-vaccination: a pilot study. Sex Health. 2010;7(3):253–261. doi:10.1071/SH0914220719212
   PubMed Web of Science ®Google Scholar
• Ushikai M, Fujiyoshi T, Kono M, et al. Detection and cloning of human papillomavirus DNA associated with recurrent respiratory papillomatosis in Thailand. Jpn J Cancer Res. 1994;85(7):699–703. doi:10.1111/j.1349-7006.1994.tb02417.x8071111
   PubMedGoogle Scholar
• Bomholt A. Juvenile laryngeal papillomatosis. An epidemiological study from the Copenhagen region. Acta Otolaryngol. 1988;105(3–4):367–371. doi:10.3109/000164888090970203389122
   PubMed Web of Science ®Google Scholar
• Lindeberg H, Elbrønd O. Laryngeal papillomas: the epidemiology in a Danish subpopulation 1965-1984. Clin Otolaryngol Allied Sci. 1990;15(2):125–131. doi:10.1111/j.1365-2273.1990.tb00444.x2350888
   PubMed Web of Science ®Google Scholar
• Omland T, Akre H, Vårdal M, Brøndbo K. Epidemiological aspects of recurrent respiratory papillomatosis: a population-based study. Laryngoscope. 2012;122(7):1595–1599. doi:10.1002/lary.2332722565595
   PubMed Web of Science ®Google Scholar
• Derkay CS. Task force on recurrent respiratory papillomas: a preliminary report. Arch Otolaryngol - Head Neck Surg. 1995;121(12):1386–1391. doi:10.1001/archotol.1995.018901200440087488368
   PubMedGoogle Scholar
• Armstrong LR, Preston EJ, Reichert M, et al. Incidence and prevalence of recurrent respiratory papillomatosis among children in Atlanta and Seattle. Clin Infect Dis. 2000;31(1):107–109. doi:10.1086/31391410913405
   PubMed Web of Science ®Google Scholar
• Marsico M, Mehta V, Chastek B, Liaw K-L, Derkay C. Estimating the incidence and prevalence of juvenile-onset recurrent respiratory papillomatosis in publicly and privately insured claims databases in the United States. Sex Transm Dis. 2014;41(5):300–305. doi:10.1097/OLQ.000000000000011524722383
   PubMed Web of Science ®Google Scholar
• Campisi P, Hawkes M, Simpson K. The epidemiology of juvenile onset recurrent respiratory papillomatosis derived from a population level national database. Laryngoscope. 2010;120(6):1233–1245. doi:10.1002/lary.2090120513045
   PubMed Web of Science ®Google Scholar
• Soldatski IL, Onufrieva EK, Steklov AM, Schepin NV. Tracheal, bronchial, and pulmonary papillomatosis in children. Laryngoscope. 2005;115(10):1848–1854. doi:10.1097/01.mlg.0000173155.57491.2a16222208
   PubMed Web of Science ®Google Scholar
• Pignatari S, Smith EM, Gray SD, Shive C, Turek LP. Detection of human papillomavirus infection in diseased and nondiseased sites of the respiratory tract in recurrent respiratory papillomatosis patients by DNA hybridization. Ann Otol Rhinol Laryngol. 1992;101(5):408–412. doi:10.1177/0003489492101005061315130
   PubMed Web of Science ®Google Scholar
• Komloš KF, Kocjan BJ, Košorok P, et al. Tumor-specific and gender-specific pre-vaccination distribution of human papillomavirus types 6 and 11 in anogenital warts and laryngeal papillomas: a study on 574 tissue specimens. J Med Virol. 2012;84(8):1233–1241. doi:10.1002/jmv.2331822711351
   PubMed Web of Science ®Google Scholar
• Buchinsky FJ, Donfack J, Derkay CS, et al. Age of child, more than HPV type, is associated with clinical course in recurrent respiratory papillomatosis. PLoS One. 2008;3(5):e2263. doi:10.1371/journal.pone.000226318509465
   PubMed Web of Science ®Google Scholar
• Buchinsky FJ, Valentino WL, Ruszkay N, et al. Age at diagnosis, but not HPV type, is strongly associated with clinical course in recurrent respiratory papillomatosis. PLoS One. 2019;14(6):e0216697. doi:10.1371/journal.pone.021669731194767
   PubMed Web of Science ®Google Scholar
• Kocjan BJ, Gale N, Hocevar Boltezar I, et al. Identical human papillomavirus (HPV) genomic variants persist in recurrent respiratory papillomatosis for up to 22 years. J Infect Dis. 2012. doi:10.1093/infdis/jis733
   Web of Science ®Google Scholar
• Rimell FL, Shoemaker DL, Pou AM, Jordan JA, Post JC, Ehrlich GD. Pediatric respiratory papillomatosis: prognostic role of viral typing and cofactors. Laryngoscope. 1997;107(7):915–918. doi:10.1097/00005537-199707000-000159217130
   PubMed Web of Science ®Google Scholar
• Carvalho CM, Huot L, Charlois A-L, Khalfallah SA, Chapuis F, Froehlich P. Prognostic factors of recurrent respiratory papillomatosis from a registry of 72 patients. Acta Otolaryngol. 2009;129(4):462–470. doi:10.1080/0001648090273798619235575
   PubMed Web of Science ®Google Scholar
• Shehata BM, Otto KJ, Sobol SE, et al. E6 and E7 oncogene expression by human papilloma virus (HPV) and the aggressive behavior of recurrent laryngeal papillomatosis (RLP). Pediatr Dev Pathol. 2008;11(2):118–121. doi:10.2350/06-09-0160.117990904
   PubMed Web of Science ®Google Scholar
• Maloney EM, Unger ER, Tucker RA, et al. Longitudinal measures of human papillomavirus 6 and 11 viral loads and antibody response in children with recurrent respiratory papillomatosis. Arch Otolaryngol Head Neck Surg. 2006;132(7):711–715. doi:10.1001/archotol.132.7.71116847177
   PubMedGoogle Scholar
• Draganov P, Todorov S, Todorov I, Karchev T, Kalvatchev Z. Identification of HPV DNA in patients with juvenile-onset recurrent respiratory papillomatosis using SYBR Green real-time PCR. Int J Pediatr Otorhinolaryngol. 2006;70(3):469–473. doi:10.1016/j.ijporl.2005.07.01816137771
   PubMed Web of Science ®Google Scholar
• Hartley C, Hamilton J, Birzgalis AR, Farrington WT. Recurrent respiratory papillomatosis–the Manchester experience, 1974-1992. J Laryngol Otol. 1994;108(3):226–229. doi:10.1017/S00222151001263508169504
   PubMed Web of Science ®Google Scholar
• Wiatrak BJ, Wiatrak DW, Broker TR, Lewis L. Recurrent respiratory papillomatosis: a longitudinal study comparing severity associated with human papilloma viral types 6 and 11 and other risk factors in a large pediatric population. Laryngoscope. 2004;114(11Pt 2 Suppl 104):1–23. doi:10.1097/01.mlg.000148224.83491.0f
   Web of Science ®Google Scholar
• Padayachee A, Prescott CA. Relationship between the clinical course and HPV typing of recurrent laryngeal papillomatosis. The Red Cross War Memorial Children’s Hospital experience 1982-1988. Int J Pediatr Otorhinolaryngol. 1993;26(2):141–147. doi:10.1016/0165-5876(93)90019-Y8383099
   PubMed Web of Science ®Google Scholar
• Rabah R, Lancaster WD, Thomas R, Gregoire L. Human papillomavirus-11-associated recurrent respiratory papillomatosis is more aggressive than human papillomavirus-6-associated disease. Pediatr Dev Pathol. 2001;4(1):68–72. doi:10.1007/s10024001010511200493
   PubMed Web of Science ®Google Scholar
• Somers GR, Tabrizi SN, Borg AJ, Garland SM, Chow CW. Juvenile laryngeal papillomatosis in a pediatric population: a clinicopathologic study. Pediatr Pathol Lab Med. 1997;17(1):53–64. doi:10.1080/155138197091683469050060
   PubMed Web of Science ®Google Scholar
• Seedat RY, Thukane M, Jansen AC, Rossouw I, Goedhals D, Burt FJ. HPV types causing juvenile recurrent laryngeal papillomatosis in South Africa. Int J Pediatr Otorhinolaryngol. 2010;74(3):255–259. doi:10.1016/j.ijporl.2009.11.01620018386
   PubMed Web of Science ®Google Scholar
• Abramson AL, Steinberg BM, Winkler B. Laryngeal papillomatosis: clinical, histopathologic and molecular studies. Laryngoscope. 1987;97(6):678–685. doi:10.1288/00005537-198706000-000053035299
   PubMed Web of Science ®Google Scholar
• Gerein V, Schmandt S, Babkina N, Barysik N, Coerdt W, Pfister H. Human papilloma virus (HPV)-associated gynecological alteration in mothers of children with recurrent respiratory papillomatosis during long-term observation. Cancer Detect Prev. 2007;31(4):276–281. doi:10.1016/j.cdp.2007.07.00417935912
   PubMedGoogle Scholar
• Silverberg MJ, Thorsen P, Lindeberg H, Grant LA, Shah KV. Condyloma in pregnancy is strongly predictive of juvenile-onset recurrent respiratory papillomatosis. Obstet Gynecol. 2003;101(4):645–652. doi:10.1016/s0029-7844(02)03081-812681865
   PubMed Web of Science ®Google Scholar
• Kashima HK, Shah F, Lyles A, et al. A comparison of risk factors in juvenile-onset and adult-onset recurrent respiratory papillomatosis. Laryngoscope. 1992;102(1):9–13. doi:10.1288/00005537-199201000-000021309932
   PubMed Web of Science ®Google Scholar
• Reyes LM, Aguilar JL, Villamor P, et al. Clinical and sociodemographic characteristics associated with disease severity in juvenile recurrent respiratory papillomatosis: a study of 104 patients in a tertiary care pediatric hospital. Int J Pediatr Otorhinolaryngol. 2018;108:63–66. doi:10.1016/j.ijporl.2018.02.02529605367
   PubMed Web of Science ®Google Scholar
• Hawkes M, Campisi P, Zafar R, et al. Time course of juvenile onset recurrent respiratory papillomatosis caused by human papillomavirus. Pediatr Infect Dis J. 2008;27(2):149–154. doi:10.1097/INF.0b013e318159833e18174855
   PubMed Web of Science ®Google Scholar
• Seedat RY. The incidence and prevalence of juvenile-onset recurrent respiratory papillomatosis in the Free State province of South Africa and Lesotho. Int J Pediatr Otorhinolaryngol. 2014;78(12):2113–2115. doi:10.1016/j.ijporl.2014.09.01725300480
   PubMed Web of Science ®Google Scholar
• Maïga S, Ndiaye C, Diouf M, et al. Laryngeal papillomatosis in Senegal: a ten-year experience. Eur Ann Otorhinolaryngol Head Neck Dis. 2018;135(3):221–224. doi:10.1016/j.anorl.2018.01.00229396224
   PubMed Web of Science ®Google Scholar
• Mulwafu W, Ensink R, Kuper H, Fagan J. Survey of ENT services in sub-Saharan Africa: little progress between 2009 and 2015. Glob Health Action. 2017;10(1):1289736. doi:10.1080/16549716.2017.128973628485648
   PubMed Web of Science ®Google Scholar
• Peer S, Vial I, Numanoglu A, Fagan JJ. What is the availability of services for paediatric ENT surgery and paediatric surgery in Africa? Eur Ann Otorhinolaryngol Head Neck Dis. 2018;135(5):S79–S83. doi:10.1016/j.anorl.2018.07.00530143398
   PubMed Web of Science ®Google Scholar
• Wagner R, Fagan J. Survey of otolaryngology services in Central America: need for a comprehensive intervention. Otolaryngol Head Neck Surg. 2013;149(5):674–678. doi:10.1177/019459981350597224057675
   PubMedGoogle Scholar
• Majumder SMKA, Ibrahim MF, Huda QKKMN, Bhattacharjee N, Amin MN. Recurrent respiratory papillomatosis: a study of 24 cases. Bangladesh Med Res Counc Bull. 1999;25(2):46–50.11026935
   PubMedGoogle Scholar
• Muriithi CM Recurrent respiratory papillomatosis at Kenyatta National Hospital, Nairobi-Kenya A ten year retrospective study between January 1990-December 1999. [dissertation]. Nairobi: University of Nairobi; 2001.
   Google Scholar
• Fasunla AJ, Lasisi OA. Diagnostic challenges of laryngeal papillomatosis and its implications among children in developing country. Int J Pediatr Otorhinolaryngol. 2009;73(4):593–595. doi:10.1016/j.ijporl.2008.12.00919157575
   PubMed Web of Science ®Google Scholar
• Orji FT, Okorafor IA, Akpeh JO. Experience with recurrent respiratory papillomatosis in a developing country: impact of tracheostomy. World J Surg. 2012;37(2):339–343. doi:10.1007/s00268-012-1839-y
   Web of Science ®Google Scholar
• Adoga AA, Nimkur LT, Adoga AS. Recurrent respiratory papillomatosis in Jos, Nigeria: clinical presentation, management and outcome. East Cent African J Surg. 2008;13(2):105–108.
   Google Scholar
• Timbo SK, Konipo-Togola F, Mohamed AA, Keita MA, Sacko HB, Traore L. Papillomatose laryngée au Mali. À propos de 19 cas colligés à l’hôpital Gabriel-Touré de Bamako. Bull Soc Pathol Exot. 2002;95(1):31–33.12012961
   PubMed Web of Science ®Google Scholar
• Intakorn P, Sonsuwan N. Human papillomatosis genotyping and severity in patients with recurrent respiratory papillomatosis. J Med Assoc Thai. 2014;97(Suppl 6):S136–S141.
   Google Scholar
• Grobbelaar J, Seedat RY, Brown S, Claassen AJ. Pulmonary hypertension due to recurrent juvenile laryngeal papillomatosis. Int J Pediatr Otorhinolaryngol. 2005;69(9):1279–1282. doi:10.1016/j.ijporl.2005.03.01916061114
   PubMed Web of Science ®Google Scholar
• Armstrong LR, Derkay CS, Reeves WC. Initial results from the national registry for juvenile-onset recurrent respiratory papillomatosis. RRP task force. Arch Otolaryngol Head Neck Surg. 1999;125(7):743–748. doi:10.1001/archotol.125.7.74310406310
   PubMedGoogle Scholar
• Lindeberg H, Elbrønd O. Laryngeal papillomas: clinical aspects in a series of 231 patients. Clin Otolaryngol. 1989;14(4):333–342. doi:10.1111/j.1365-2273.1989.tb00381.x2805372
   PubMed Web of Science ®Google Scholar
• Gélinas J-F, Manoukian J, Côté A. Lung involvement in juvenile onset recurrent respiratory papillomatosis: a systematic review of the literature. Int J Pediatr Otorhinolaryngol. 2008;72(4):433–452. doi:10.1016/j.ijporl.2007.12.00318281102
   PubMed Web of Science ®Google Scholar
• Lawlor C, Balakrishnan K, Bottero S, et al. International Pediatric Otolaryngology Group (IPOG): juvenile-onset recurrent respiratory papillomatosis consensus recommendations. Int J Pediatr Otorhinolaryngol. 2020;128:109697. doi:10.1016/j.ijporl.2019.10969731698245
   PubMed Web of Science ®Google Scholar
• Suter-Montano T, Montaño E, Martínez C, Plascencia T, Sepulveda MT, Rodríguez M. Adult recurrent respirator papillomatosis: a new therapeutic approach with pegylated interferon alpha 2a (Peg-IFNα-2a) and GM-CSF. Otolaryngol Head Neck Surg. 2013;148(2):253–260. doi:10.1177/019459981246622623124924
   PubMed Web of Science ®Google Scholar
• Lee AS, Rosen CA. Efficacy of cidofovir injection for the treatment of recurrent respiratory papillomatosis. J Voice. 2004;18(4):551–556. doi:10.1016/j.jvoice.2003.07.00715567056
   PubMed Web of Science ®Google Scholar
• Ongkasuwan J, Friedman EM. Juvenile recurrent respiratory papilloma: variable intersurgical intervals. Laryngoscope. 2012;122(12):2844–2849. doi:10.1002/lary.2353422847877
   PubMed Web of Science ®Google Scholar
• Montaño-Velázquez BB, Nolasco-Renero J, Parada-Bañuelos JE, et al. Quality of life of young patients with recurrent respiratory papillomatosis. J Laryngol Otol. 2017;131(5):425–428. doi:10.1017/S002221511700035428193306
   PubMed Web of Science ®Google Scholar
• Chadha NK, Allegro J, Barton M, Hawkes M, Harlock H, Campisi P. The quality of life and health utility burden of recurrent respiratory papillomatosis in children. Otolaryngol Head Neck Surg. 2010;143(5):685–690. doi:10.1016/j.otohns.2010.08.00520974340
   PubMed Web of Science ®Google Scholar
• Combrinck CE, Seedat RY, Burt FJ. FRET-based detection and genotyping of HPV-6 and HPV-11 causing recurrent respiratory papillomatosis. J Virol Methods. 2013;189:271–276. doi:10.1016/j.jviromet.2013.01.02523473839
   PubMed Web of Science ®Google Scholar
• Cuello G, Sánchez GI, Jaramillo R, et al. Clinical characteristics and HPV type in recurrent respiratory papillomatosis in Colombia. Salud Publica Mex. 2013;55(4):416–420. doi:10.21149/spm.v55i4.722624165718
   PubMed Web of Science ®Google Scholar
• Gáll T, Kis A, Tatár TZ, Kardos G, Gergely L, Szarka K. Genomic differences in the background of different severity in juvenile-onset respiratory papillomatoses associated with human papillomavirus type 11. Med Microbiol Immunol. 2013;202(5):353–363. doi:10.1007/s00430-013-0297-y23649705
   PubMed Web of Science ®Google Scholar
• Jelen MM, Chen Z, Kocjan BJ, et al. Global genomic diversity of human papillomavirus 6 based on 724 isolates and 190 complete genome sequences. J Virol. 2014;88(13):7307–7316. doi:10.1128/JVI.00621-1424741079
   PubMed Web of Science ®Google Scholar
• Jelen MM, Chen Z, Kocjan BJ, et al. Global genomic diversity of human papillomavirus 11 based on 433 isolates and 78 complete genome sequences. J Virol. 2016;90(11):5503–5513. doi:10.1128/JVI.03149-1527030261
   PubMed Web of Science ®Google Scholar
• Seedat RY, Combrinck CE, Bester PA, Lee J-Y, Burt FJ. Determination of the complete genome and functional analysis of HPV6 isolate VBD19/10 from a patient with aggressive recurrent respiratory papillomatosis. Epidemiol Infect. 2016;144(10):2128–2135. doi:10.1017/S095026881600038826931553
   PubMed Web of Science ®Google Scholar
• Moreddu E, Lambert E, Kacmarynski D, Nicollas R, Triglia J-M, Smith RJ. Risk factors for severity of juvenile-onset recurrent respiratory papillomatosis at first endoscopy. Eur Ann Otorhinolaryngol Head Neck Dis. 2019;136(1):25–28. doi:10.1016/j.anorl.2018.11.00730503689
   PubMed Web of Science ®Google Scholar
• El Achkar VNR, Duarte A, Carlos R, et al. Histopathological features of juvenile‐onset laryngeal papillomatosis related to severity. Head Neck. 2019;41(5):1412–1417. doi:10.1002/hed.2560230623508
   PubMed Web of Science ®Google Scholar
• Malick N, Cheikh NI, Arnaud IOF, et al. Laryngeal papillomatosis in children. Oto-Rhino-Laryngologie Française. 2008;94:379–381.
   Google Scholar
• Aliyu MK, Abimiku SL, Babagana MA, Musa E. Recurrent respiratory papillomatosis: management outcome at national ear care centre, Kaduna. Borno Med J. 2010;7(2):5–7.
   Google Scholar
• Holler T, Allegro J, Chadha NK, et al. Voice outcomes following repeated surgical resection of laryngeal papillomata in children. Otolaryngol Head Neck Surg. 2009;141(4):522–526. doi:10.1016/j.otohns.2009.06.08019786223
   PubMed Web of Science ®Google Scholar
• Hermann JS, Pontes P, Weckx LLM, Fujita R, Avelino M, Pignatari SSN. Laryngeal sequelae of recurrent respiratory papillomatosis surgery in children. Rev Assoc Med Bras. 2012;58(2):204–208. doi:10.1016/S0104-4230(12)70181-122569615
   PubMed Web of Science ®Google Scholar
• Antarasena S. Clinical study of juvenile laryngeal papilloma. Acta Otolaryngol Suppl. 1988;458:163–166. doi:10.3109/000164888091251233245425
   PubMedGoogle Scholar
• Ilmarinen T, Nissilä H, Rihkanen H, et al. Clinical features, health-related quality of life, and adult voice in juvenile-onset recurrent respiratory papillomatosis. Laryngoscope. 2011;121(4):846–851. doi:10.1002/lary.2133221400536
   PubMed Web of Science ®Google Scholar
• Graupp M, Gugatschka M, Kiesler K, Reckenzaun E, Hammer G, Friedrich G. Experience of 11 years use of cidofovir in recurrent respiratory papillomatosis. Eur Arch Otorhinolaryngol. 2013;270(2):641–646. doi:10.1007/s00405-012-2221-223070260
   PubMed Web of Science ®Google Scholar
• Valera F, Maldonato L, Lima J, et al. Efficacy of cidofovir in recurrent juvenile respiratory papillomatosis. Braz J Otorhinolaryngol. 2010;76(6):713–717. doi:10.1590/S1808-8694201000060000821180938
   PubMed Web of Science ®Google Scholar
• Derkay C. Cidofovir for recurrent respiratory papillomatosis (RRP): a re-assessment of risks. Int J Pediatr Otorhinolaryngol. 2005;69(11):1465–1467. doi:10.1016/j.ijporl.2005.08.00716174538
   PubMed Web of Science ®Google Scholar
• Chadha NK, James A. Adjuvant antiviral therapy for recurrent respiratory papillomatosis. Cochrane Database Syst Rev. 2012;12(1):CD005053. doi:10.1002/14651858.CD005053.pub423235619
   PubMed Web of Science ®Google Scholar
• McMurray JS, Connor N, Ford CN. Cidofovir efficacy in recurrent respiratory papillomatosis: a randomized, double-blind, placebo-controlled study. Ann Otol Rhinol Laryngol. 2008;117(7):477–483. doi:10.1177/00034894081170070218700421
   PubMed Web of Science ®Google Scholar
• Maturo S, Hartnick CJ. Use of 532-nm pulsed potassium titanyl phosphate laser and adjuvant intralesional bevacizumab for aggressive respiratory papillomatosis in children: initial experience. Arch Otolaryngol Head Neck Surg. 2010;136(6):561–565. doi:10.1001/archoto.2010.8120566906
   PubMedGoogle Scholar
• Mohr M, Schliemann C, Biermann C, et al. Rapid response to systemic bevacizumab therapy in recurrent respiratory papillomatosis. Oncol Lett. 2014;8(5):1912–1918. doi:10.3892/ol.2014.248625289079
   PubMed Web of Science ®Google Scholar
• Zur KB, Fox E. Bevacizumab chemotherapy for management of pulmonary and laryngotracheal papillomatosis in a child. Laryngoscope. 2017;127(7):1538–1542. doi:10.1002/lary.2645027996119
   PubMed Web of Science ®Google Scholar
• Mitra S, Das A, Ghosh D, Sengupta A. Postoperative systemic acyclovir in juvenile-onset recurrent respiratory papillomatosis: the outcome. Ear Nose Throat J. 2019;98(1):28–31. doi:10.1177/014556131882331130834790
   PubMed Web of Science ®Google Scholar
• Pashley NRT. Can mumps vaccine induce remission in recurrent respiratory papilloma? Arch Otolaryngol Head Neck Surg. 2002;128(7):783–786. doi:10.1001/archotol.128.7.78312117334
   PubMedGoogle Scholar
• Wang Y, Dai PD, Zhang TY. Experimental research on the therapeutic effect of MMR vaccine to juvenile-onset recurrent respiratory papillomatosis. Eur Arch Oto-Rhino-Laryngol. 2019;276(3):801–803. doi:10.1007/s00405-019-05351-6
   Web of Science ®Google Scholar
• Lei J, Yu W, Yuexin L, Qi C, Xiumin S, Tianyu Z. Topical measles-mumps-rubella vaccine in the treatment of recurrent respiratory papillomatosis: results of a preliminary randomized, controlled trial. Ear Nose Throat J. 2012;91(4):174–175. doi:10.1177/01455613120910041122522357
   PubMed Web of Science ®Google Scholar
• Formánek M, Komínek P, Jančatová D, et al. Laryngopharyngeal reflux is a potential risk factor for juvenile-onset recurrent respiratory papillomatosis. Biomed Res Int. 2019;2019:1463896. doi:10.1155/2019/146389630881982
   PubMed Web of Science ®Google Scholar
• Novakovic D, Cheng ATL, Zurynski Y, et al. A prospective study of the incidence of juvenile-onset recurrent respiratory papillomatosis after implementation of a national HPV vaccination program. J Infect Dis. 2018;217(2):208–212. doi:10.1093/infdis/jix49829136168
   PubMed Web of Science ®Google Scholar
• World Health Organization. Global Market Study: HPV Vaccines; 2019 Available from: https://www.who.int/immunization/programmes_systems/procurement/v3p/platform/module2/WHO_HPV_market_study_public_summary.pdf. Accessed September 30, 2019.
   Google Scholar
• Rosenberg T, Philipsen BB, Mehlum CS, et al. Therapeutic use of the human papillomavirus vaccine on recurrent respiratory papillomatosis: a systematic review and meta-analysis. J Infect Dis. 2019;219(7):1016–1025. doi:10.1093/infdis/jiy61630358875
   PubMed Web of Science ®Google Scholar
• Verma H, Solanki P, James M. Acoustical and perceptual voice profiling of children with recurrent respiratory papillomatosis. J Voice. 2016;30(5):600–605. doi:10.1016/j.jvoice.2015.06.00826474713
   PubMed Web of Science ®Google Scholar